Auckland, New Zealand

Ray Xingyu Zhuang

This inventor holds 1 USPTO granted patent. Top assignee: Fisher & Paykel Healthcare Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ray Xingyu Zhuang. Retrieved from https://idiyas.com/inventor/ray-xingyu-zhuang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ray Xingyu Zhuang: Innovator in Graphical User Interfaces

Introduction

Ray Xingyu Zhuang is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of graphical user interfaces, showcasing his innovative spirit through his patent work.

Latest Patents

Zhuang holds a patent for a display screen or portion thereof with a graphical user interface. This invention reflects his commitment to enhancing user experience through technology. He has 1 patent to his name, demonstrating his capability as an inventor.

Career Highlights

Ray Xingyu Zhuang is currently employed at Fisher & Paykel Healthcare Limited. His role at this esteemed company allows him to work on cutting-edge technologies that improve healthcare solutions.

Collaborations

Zhuang collaborates with talented individuals such as Yijun Ren and Nathanael Charles Gray. Their teamwork fosters an environment of innovation and creativity within the company.

Conclusion

Ray Xingyu Zhuang is a dedicated inventor whose work in graphical user interfaces has the potential to impact the technology landscape significantly. His contributions at Fisher & Paykel Healthcare Limited and his collaborations with fellow innovators highlight his commitment to advancing technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…